Schmid C, Tjan T, Etz C, Welp H, Rukosujew A, Klotz S, Drees G, Gogarten W, Scheld H H
Thoracic and Cardiovascular Surgery, University of Münster, Münster, Germany.
Thorac Cardiovasc Surg. 2006 Sep;54(6):393-9. doi: 10.1055/s-2006-924268.
We report on our experience with the BerlinHeart Excor system in adults and paediatric patients who underwent placement of the mechanical support device under emergency conditions and demonstrate the exceptional advantages and the considerable versatility of the system.
Since 2003, 29 consecutive patients (25 adults and 4 infants) with ages ranging from 10 months to 54 years underwent implantation of an Excor system. Main underlying heart diseases in adults were acute myocardial infarction (n = 9), dilative cardiomyopathy (n = 6), acute myocarditis (n = 6), whereas most of the children suffered from dilative cardiomyopathy. Ten patients had undergone implantation of an extracorporeal membrane oxygenation system.
In 26 cases, a left ventricular assist device (LVAD) was implanted, while 3 patients had biventricular support. The support interval of all patients surviving the perioperative period lasted from 30 to 412 days, mean period of support until heart transplantation or explantation was 184 +/- 117 days. Severe complications were rare.
The Excor paracorporeal mechanical support system is an excellent and highly versatile device for the support of patients of all ages and different types of underlying heart disease in the mid-term and long-term. The implant procedure and the perioperative management are simple, and complication rates are low.
我们报告了在紧急情况下为成人和儿科患者植入柏林心脏Excor系统的经验，并展示了该系统的独特优势和广泛的适用性。
自2003年以来，连续29例年龄在10个月至54岁之间的患者（25例成人和4例婴儿）接受了Excor系统植入。成人主要潜在心脏病为急性心肌梗死（n = 9）、扩张型心肌病（n = 6）、急性心肌炎（n = 6），而大多数儿童患有扩张型心肌病。10例患者曾接受体外膜肺氧合系统植入。
26例植入左心室辅助装置（LVAD），3例接受双心室支持。所有围手术期存活患者的支持时间为30至412天，直至心脏移植或取出装置的平均支持时间为184±117天。严重并发症罕见。
Excor体外机械支持系统是一种出色且适用性广泛的装置，可用于中期和长期支持各年龄段及不同类型潜在心脏病患者。植入过程和围手术期管理简单，并发症发生率低。
